Supplier Management Service

Under FDA's Quality Management System Regulation, effective February 2, 2026, investigators can review your supplier audit reports along with the evaluations, monitoring records and corrective actions behind them. For small and midsize manufacturers, keeping that program current is a capacity problem as much as a knowledge problem. Kapstone Medical runs your supplier quality program on an ongoing basis, inside your procedures and your eQMS, so your records stay current and your team keeps ownership.

 

What's included:

    • Supplier qualification: evaluation of new suppliers against your criteria, with audits where risk requires them.
    • Risk-based classification: suppliers grouped by the risk of what they supply, with controls set for each group (ISO 13485 clause 7.4.1).
    • Supplier audits: on-site or remote audits on a risk-based schedule, with reports written to stand on their own.
    • Performance monitoring: quality and delivery tracking and scheduled re-evaluations.
    • Approved supplier list: maintained and current in your eQMS.
    • SCAR management: issue, track and verify effectiveness of supplier corrective actions.
    • Remediation: revisions to purchasing procedures, supplier forms and quality agreements where gaps exist.

How it works

  1. Assess: review your supplier procedures, approved supplier list and open supplier issues.
  2. Set up: agree responsibilities in a quality agreement, classify suppliers by risk and set the audit and re-evaluation schedule.
  3. Run: perform the recurring work under your procedures, in your eQMS.
  4. Report: provide regular status on supplier performance, open SCARs and upcoming audits for your quality and management reviews.

Who is it for?

Small and midsize device manufacturers with limited quality staff; companies preparing for a first FDA inspection; companies whose supplier base has grown faster than their quality team; and companies updating QS-era supplier procedures for the QMSR.

Verified Review on Clutch: Quality & Regulatory for ExoToe

Quality & Regulatory Consulting for Medical Device Company

"Our previous system had gaps we needed to rectify, and the updated QMS helped us achieve FDA compliance."

Kapstone Medical delivered the client's new implant, packaging, and sizers, updated their DHF, and completed their QMS, enabling the client to achieve FDA compliance. The team completed the project on time, with some expected minor delays. Their CEO was also hands-on and always involved."

Michael S. Lee, DPM, FACFAS

President, ExoToe

Supplier Management FAQs

No. Under ISO 13485 clause 4.1.5, which the QMSR incorporates, the manufacturer keeps responsibility for outsourced processes. Kapstone works under your procedures, and your quality management approves suppliers and closes corrective actions.

Yes. FDA states that the QMSR gives it authority to inspect supplier audit reports, quality audits and management review records. The exception in the former 21 CFR 820.180(c) was not carried into the QMSR.

No. We work in your existing system. Where we find gaps, we propose revisions for your approval.

By the risk of the purchased product or service to the quality of your device, as ISO 13485 clause 7.4.1 requires, together with each supplier's performance history.

Largely no. FDA describes the former QS regulation and the QMSR as substantially similar. What changed is that supplier audit records can now be reviewed and that FDA's inspection program treats outsourcing and purchasing as one of six inspection areas.

Ready to get to work?
If Kapstone sounds like the right fit for your business or you have further questions, please reach out to our team.

Get in Touch